Published: 19-12-2022
Review
Chylothorax associated with sarcoidosis: a review of the literature
Abstract 456 | PDF Downloads 378Page e2022039
Original Articles: Clinical Research
Serum Krebs von den Lungen-6: promising biomarker to differentiate CPFE from IPF
Abstract 549 | PDF Downloads 472Page e2022035
Infliximab decreases inflammatory activity but has no effect on small fiber neuropathy related symptoms in Dutch patients with sarcoidosis
Abstract 488 | PDF Downloads 158Page e2022033
Intravenous immunoglobulin for acute exacerbation of fibrotic idiopathic interstitial pneumonias
Abstract 766 | PDF Downloads 614Page e2022038
Role of computed tomography findings, complete blood count parameters and systemic inflammatory markers for predicting the severity in interstitial lung diseases
Abstract 621 | PDF Downloads 384Page e2022042
Original Articles: Laboratory Research
Metagenomic sequencing of the bronchoalveolar lavage extracellular virome and cellular transcriptome of sarcoidosis patients does not detect rubella virus
Abstract 476 | PDF Downloads 419Page e2022040
Case Reports
A case of hepatic and bone marrow sarcoidosis with progressive renal failure: diagnostic and therapeutic challenges
Abstract 405 | PDF Downloads 374Page e2022041
Letter to Editor
Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy
Abstract 383 | PDF Downloads 329Page e2022036
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis
Abstract 323 | PDF Downloads 307Page e2022037